Danilov AV - Search Results

1

Cardiac non-Hodgkin's lymphoma: clinical characteristics and trends in survival.

Gordon MJ, Danilova O, Spurgeon S, Danilov AV. Gordon MJ, et al. Among authors: danilov av. Eur J Haematol. 2016 Nov;97(5):445-452. doi: 10.1111/ejh.12751. Epub 2016 Mar 30. Eur J Haematol. 2016. PMID: 26935129

2

Molecular pathogenesis of chronic lymphocytic leukemia.

Danilov AV, Danilova OV, Klein AK, Huber BT. Danilov AV, et al. Curr Mol Med. 2006 Sep;6(6):665-75. doi: 10.2174/156652406778195008. Curr Mol Med. 2006. PMID: 17022736 Review.

3

AIDS-related Burkitt lymphoma--a heterogeneous disease?

Danilov AV, Pilichowska M, Danilova OV, Sprague KA. Danilov AV, et al. Leuk Res. 2008 Dec;32(12):1939-41. doi: 10.1016/j.leukres.2008.03.037. Epub 2008 May 9. Leuk Res. 2008. PMID: 18472158 No abstract available.

4

Cell cycle control and adhesion signaling pathways in the development of metastatic melanoma.

Danilov AV, Danilova OV, Huber BT. Danilov AV, et al. Cancer Metastasis Rev. 2008 Dec;27(4):707-14. doi: 10.1007/s10555-008-9159-2. Cancer Metastasis Rev. 2008. PMID: 18496651 Review.

5

Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia.

Danilov AV, Danilova OV, Brown JR, Rabinowitz A, Klein AK, Huber BT. Danilov AV, et al. Exp Hematol. 2010 Dec;38(12):1167-77. doi: 10.1016/j.exphem.2010.08.008. Epub 2010 Sep 24. Exp Hematol. 2010. PMID: 20817072 Free PMC article.

6

Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.

Humphries LA, Godbersen JC, Danilova OV, Kaur P, Christensen BC, Danilov AV. Humphries LA, et al. Among authors: danilov av. Br J Haematol. 2013 Dec;163(5):590-602. doi: 10.1111/bjh.12580. Epub 2013 Sep 30. Br J Haematol. 2013. PMID: 24117128 Free PMC article.

7

The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells.

Godbersen JC, Humphries LA, Danilova OV, Kebbekus PE, Brown JR, Eastman A, Danilov AV. Godbersen JC, et al. Among authors: danilov av. Clin Cancer Res. 2014 Mar 15;20(6):1576-89. doi: 10.1158/1078-0432.CCR-13-0987. Clin Cancer Res. 2014. PMID: 24634471 Free PMC article.

8

MIR21 is differentially expressed in the lymphoid tissue and modulated by stromal signalling in chronic lymphocytic leukaemia.

Danilova OV, Paiva C, Kaur P, Kamal A, Sempere LF, Danilov AV. Danilova OV, et al. Among authors: danilov av. Br J Haematol. 2015 Jul;170(2):272-5. doi: 10.1111/bjh.13282. Epub 2015 Jan 29. Br J Haematol. 2015. PMID: 25643738 Free article. No abstract available.

9

FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.

Danilova OV, Dumont LJ, Levy NB, Lansigan F, Kinlaw WB, Danilov AV, Kaur P. Danilova OV, et al. Among authors: danilov av. J Hematop. 2013 Mar;6(1):11-18. doi: 10.1007/s12308-012-0166-4. J Hematop. 2013. PMID: 25937841 Free PMC article.

10

Targeting neddylation effectively antagonizes nuclear factor-κB in chronic lymphocytic leukemia B-cells.

Godbersen JC, Paiva C, Danilova OV, Berger A, Brown JR, Danilov AV. Godbersen JC, et al. Among authors: danilov av. Leuk Lymphoma. 2015 May;56(5):1566-9. doi: 10.3109/10428194.2014.990901. Leuk Lymphoma. 2015. PMID: 26086969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page